Trade Summary

1 month ago, Choo Chee Kong, serving as Dir at CytoMed Therapeutics Ltd (GDTC), purchased 112,000 shares at $1.15 per share, for a total transaction value of $128,777.60. Following this transaction, Choo Chee Kong now holds 430,324 shares of GDTC.

This purchase represents a 35.18% increase in Choo Chee Kong's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 13, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 15, 2026 at 6:15 AM ET, 33 days after the trade was made.